Trial design in psoriatic arthritis: what could be changed?

Kavanaugh, A.; Boyd, T.

Clinical and Experimental Rheumatology 33(4 Suppl 92: S15-S18

2015


ISSN/ISBN: 0392-856X
PMID: 26458015
Document Number: 683278
A greater understanding of the underlying disease process, combined with the development of novel therapeutic agents, has led to innovative strategies in the treatment of psoriatic arthritis (PsA). This report addresses unmet needs in clinical trial design in PsA, and proposes some amendments that may yield data that can potentially improve patient outcomes in the management of PsA.

Document emailed within 1 workday
Secure & encrypted payments